Tag: Crohn’s Disease
The Hidden Strength of Moms Living with Crohn’s Disease
Motherhood with Crohn’s disease brings unique challenges that extend far beyond typical IBD symptoms. From reproductive health concerns to fertility planning, mothers with Crohn’s navigate complex decisions while caring for their families.
New Hope: Switching Infliximab Delivery Could Change IBD Life
New research shows IBD patients can successfully switch from IV to subcutaneous infliximab while maintaining remission, with over 95% staying in remission for at least one year. This could transform treatment by offering more convenience and flexibility without sacrificing effectiveness.
Green Bay’s Walk Shows How Community Support Heals IBD Isolation
The Green Bay Take Steps Walk demonstrates how community support can combat the isolation that often accompanies IBD. Beyond fundraising for research, these events create vital connections that address the psychological challenges of living with chronic illness.
Finding Hope: Michigan Medicine’s Whole-Person IBD Care Approach
University of Michigan Health’s IBD Program takes a revolutionary whole-person approach to Crohn’s and colitis care, integrating gastroenterology, surgery, nutrition, and mental health support. This comprehensive model represents a significant shift toward treating not just the disease, but the entire person living with IBD.
AI-Designed Antibiotic Could Change IBD Treatment Forever
Researchers have developed enterololin, a new AI-designed antibiotic that targets harmful gut bacteria while preserving beneficial microbes. This precision approach could revolutionize IBD treatment by avoiding the microbiome damage typically caused by traditional antibiotics.
IPAA Surgery: How Your IBD Diagnosis Shapes Your Journey
New research reveals how your specific IBD diagnosis influences IPAA surgery outcomes, with 90-95% of patients across all diagnoses reporting excellent long-term satisfaction. Understanding these diagnosis-specific differences can transform surgical fear into informed confidence.
New Crohn’s Treatment Shows 70% Success Rate in Early Trial
Amorphical’s early clinical trial shows 70% of Crohn’s patients experienced significant improvement using a novel calcium-based treatment. This research represents a fundamentally different approach from traditional IBD therapies, potentially offering hope with fewer side effects.
The Personal Treatment Revolution in Crohn’s Disease Care
The treatment landscape for Crohn’s disease has transformed dramatically, moving from limited one-size-fits-all options to personalized therapies tailored to individual symptoms, medical history, and lifestyle preferences. This shift represents more than medical progress—it offers genuine hope for better quality of life and long-term relief for the IBD community.
Beyond ‘Just Stress’: Understanding the Real Impact of Crohn’s
Living with Crohn’s means carrying an invisible burden that goes far beyond ‘just stress.’ Understanding the full impact of this complex condition—from its deep inflammation to systemic effects—can help validate your experience and guide more effective care approaches.
Tyler James Williams Opens Up About Crohn’s and Mental Health
Tyler James Williams’ brave decision to share his Crohn’s disease and mental health journey offers hope to IBD patients struggling in silence. His story highlights the critical connection between chronic illness and mental health, especially in communities where stigma prevents seeking help.
